William Blair Investment Management LLC Makes New Investment in Corteva, Inc. $CTVA

William Blair Investment Management LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 14,319 shares of the company’s stock, valued at approximately $1,213,000.

Other institutional investors also recently modified their holdings of the company. Elevation Wealth Partners LLC boosted its holdings in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after acquiring an additional 261 shares during the last quarter. Clearstead Trust LLC purchased a new position in shares of Corteva during the second quarter valued at approximately $31,000. JPL Wealth Management LLC purchased a new position in shares of Corteva during the third quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new position in Corteva during the second quarter valued at approximately $33,000. Finally, Westfuller Advisors LLC boosted its holdings in Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after purchasing an additional 387 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Get Corteva alerts:

Corteva Stock Up 0.1%

CTVA opened at $81.84 on Monday. The firm’s 50 day simple moving average is $82.13 and its two-hundred day simple moving average is $80.26. The company has a market capitalization of $54.60 billion, a PE ratio of 54.20, a PEG ratio of 2.51 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CTVA. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. UBS Group cut their price objective on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, August 18th. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. Finally, Oppenheimer raised their target price on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Get Our Latest Stock Report on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also

• Five stocks we like better than Corteva
• VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
• 3 Closed-End Funds to Maximize Dividend Payments
• Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
• $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.